Public Policy and Advocacy Committee

 View Only
last person joined: 2 years ago 

The Policy and Advocacy Committee reviews and analyzes immunotherapy and oncology related policy issues to advise the Board of Directors on the broad policy, advocacy, regulatory and value priorities of the society. The committee serves at the pleasure of the Board of Directors, representing the society when requested and supporting the development of talking points for the board when asked. The committee works with relevant subcommittees to achieve its purpose.

SITC Early Career Investigator Support - Sign on Letter

By Christian Miller posted 06-02-2020 17:43

  

The SITC Policy Committee has a lead a sign on letter focused on support for early career scientist during and after the COVID 19 Pandemic. This letter was cosigned by 8 organizations representing a diverse perspective in the field of cancer. The letter was sent to major federal government funding agencies including the National Institute of Health, National Science Foundation, Department of Defense, and the Department of Veterans Affairs. The full text for the letter can be found here. SITC thanks all of the organizations that have chosen to support this effort, and we hope to continue to provide support in any way possible for early career scientists throughout these difficult times.

Permalink